CEO at GN Hearing: Properly regulated OTC sales channel could make a difference

Upcoming regulations for the over-the-counter hearing aid market in the US could prove a positive change, as they open up for the treatment of first-time users with mild hearing loss with far better products, CEO at GN Hearing Gitte Aabo assesses.

Photo: GN Store Nord / PR

The opinion on an over-the-counter sales channel for hearings aids in the US hasn't changed at the Danish company GN Hearing. Even now, when the reality of the potential market nears.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs